Datopotamab–deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Katia Khoury, Jane Meisel, Christina Yau, Hope S. Rugo, Rita Nanda, Marie Davidian, Butch Tsiatis, A. Jo Chien, Anne M. Wallace, Mili Arora, Mariya Rozenblit, Dawn L. Hershman, Alexandra S. Zimmer, Amy S. Clark, Heather Beckwith, Anthony Elias, Erica Stringer-Reasor, Judy C. Boughey, Chaitali Nangia, Christos Vaklavas, Coral Omene, Kathy S. Albain, Kevin Kalinsky, Claudine Isaacs, Jennifer F. Tseng, Evanthia T. Roussos Torres, Brittani Thomas, Alexandra Thomas, Amy Sanford, Ronald Balassanian, Cheryl Ewing, Kay T. Yeung, Candice A. M. Sauder, Tara Sanft, Lajos Pusztai, Meghna S. Trivedi, Ashton Outhaythip, Wen Li, Natsuko Onishi, Adam L. Asare, Philip Beineke, Peter Norwood, Lamorna Brown Swigart, Gillian L. Hirst, Jeffrey B. Matthews, Brian A. Moore, W. Fraser Symmans, Elissa R. Price, Carolyn Beedle, Jane Perlmutter, Paula R. Pohlmann, Rebecca Shatsky, Angela DeMichele, Douglas Yee, Laura van ‘t Veer, Nola M. Hylton, Laura J. Esserman